OBJECTIVES: To identify the occurrence and the causes of platelet refractoriness in oncohematologic patients. INTRODUCTION: Platelet refractoriness (unsatisfactory post-transfusion platelet increment) is a severe problem that impairs the treatment of oncohematologic patients and is not routinely investigated in most Brazilian services. METHODS: Forty-four episodes of platelet concentrate transfusion were evaluated in 16 patients according to the following parameters: corrected count increment, clinical conditions and detection of anti-platelet antibodies b
Multiple platelet transfusions can induce alloimmunization. Alloimmunization involving platelet memb...
Platelet transfusion refractoriness (PTR) is an intractable issue in hematological patients, which i...
Transfusion plays an important role in the management of patients with hematological malignancies a...
OBJECTIVES: To identify the occurrence and the causes of platelet refractoriness in oncohematologic ...
BACKGROUND: Understanding the cause for platelet refractoriness in a given patient is the critical s...
International audienceThe platelet refractoriness is a complication of transfusion treatments potent...
International audiencePlatelet refractoriness is a serious complication for patients receiving recur...
BACKGROUND: Immune platelet refractoriness is mainly caused by human leukocyte antigen antibodies (8...
Platelet transfusion failure is a common phenomenon affecting from 7% to 34% of haematology-oncology...
Numerous independent and interdependent factors are in-volved in the posttransfusion platelet respon...
Development of permanent platelet refractoriness is a majar problem in multitransfused patients with...
Orientador: Vagner de CastroTese (doutorado) - Universidade Estadual de Campinas, Faculdade de Ciênc...
Children with acute leukemia often require platelet transfusions, but the platelet count frequently ...
Platelet demand is unpredictable and will relate to case mix, programmes of treatment requiring inte...
We prospectively randomized 51 patients with haematological malignancy requiring platelet concentrat...
Multiple platelet transfusions can induce alloimmunization. Alloimmunization involving platelet memb...
Platelet transfusion refractoriness (PTR) is an intractable issue in hematological patients, which i...
Transfusion plays an important role in the management of patients with hematological malignancies a...
OBJECTIVES: To identify the occurrence and the causes of platelet refractoriness in oncohematologic ...
BACKGROUND: Understanding the cause for platelet refractoriness in a given patient is the critical s...
International audienceThe platelet refractoriness is a complication of transfusion treatments potent...
International audiencePlatelet refractoriness is a serious complication for patients receiving recur...
BACKGROUND: Immune platelet refractoriness is mainly caused by human leukocyte antigen antibodies (8...
Platelet transfusion failure is a common phenomenon affecting from 7% to 34% of haematology-oncology...
Numerous independent and interdependent factors are in-volved in the posttransfusion platelet respon...
Development of permanent platelet refractoriness is a majar problem in multitransfused patients with...
Orientador: Vagner de CastroTese (doutorado) - Universidade Estadual de Campinas, Faculdade de Ciênc...
Children with acute leukemia often require platelet transfusions, but the platelet count frequently ...
Platelet demand is unpredictable and will relate to case mix, programmes of treatment requiring inte...
We prospectively randomized 51 patients with haematological malignancy requiring platelet concentrat...
Multiple platelet transfusions can induce alloimmunization. Alloimmunization involving platelet memb...
Platelet transfusion refractoriness (PTR) is an intractable issue in hematological patients, which i...
Transfusion plays an important role in the management of patients with hematological malignancies a...